Medication Adherence Budgets Rising At Pharma Firms, Report Says, But Impact Still Hard To Calculate
Executive Summary
Pharmaceutical companies are investing more money into medication adherence programs, but measuring the success of these programs remains a challenge. Consultants are recommending building adherence plans into the development of a drug, with an emphasis on understanding patients’ approaches to compliance.